Which Rivastigmine Formula is Better for Heart in Elderly Patients With Alzheimer's Disease: Oral or Patch?

Conclusion: It was demonstrated that rivastigmine formulations were not associated with increased arrhythmogenic or hypotensive effects in elderly patients with AD and was not superior to each other.

http://aja.sagepub.com/cgi/content/abstract/29/8/735?rss=1

Source: American Journal of Alzheimer's Disease and Other Dementias - November 18, 2014 Category: Geriatrics Authors: Isik, A. T., Soysal, P., Yay, A. Tags: Current Topics in Research Source Type: research